Record Information |
---|
Version | 2.0 |
---|
Created at | 2023-12-21 00:02:12 UTC |
---|
Updated at | 2024-09-03 04:18:35 UTC |
---|
NP-MRD ID | NP0332249 |
---|
Natural Product DOI | https://doi.org/10.57994/1441 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Cholesteryl palmitate |
---|
Description | CE(16:0), Also known as CE or hexadecanoate, belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. Thus, ce(16:0) Is considered to be a sterol. CE(16:0) Exists in all eukaryotes, ranging from yeast to plants to humans. CE(16:0) Is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. CE(16:0), With regard to humans, has been linked to the inborn metabolic disorder hypercholesterolemia. Cholesteryl palmitate was first documented in 1973 (PMID: 4147522). Based on a literature review a small amount of articles have been published on CE(16:0) (PMID: 3605272) (PMID: 26884207) (PMID: 3734635) (PMID: 7190843). |
---|
Structure | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCCCCCCCC)[C@H](C)CCCC(C)C InChI=1S/C43H76O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-23-41(44)45-36-28-30-42(5)35(32-36)24-25-37-39-27-26-38(34(4)22-20-21-33(2)3)43(39,6)31-29-40(37)42/h24,33-34,36-40H,7-23,25-32H2,1-6H3/t34-,36+,37+,38-,39+,40+,42+,43-/m1/s1 |
---|
Synonyms | Value | Source |
---|
(3beta)-Cholest-5-en-3-ol hexadecanoate | ChEBI | 16:0 Cholesterol ester | ChEBI | CE | ChEBI | Cholesterol palmitate | ChEBI | Cholesteryl hexadecanoate | ChEBI | Hexadecanoic acid, cholesteryl ester | ChEBI | Palmitic acid cholesteryl ester | ChEBI | (3b)-Cholest-5-en-3-ol hexadecanoate | Generator | (3b)-Cholest-5-en-3-ol hexadecanoic acid | Generator | (3beta)-Cholest-5-en-3-ol hexadecanoic acid | Generator | (3Β)-cholest-5-en-3-ol hexadecanoate | Generator | (3Β)-cholest-5-en-3-ol hexadecanoic acid | Generator | Cholesterol palmitic acid | Generator | Cholesteryl hexadecanoic acid | Generator | Hexadecanoate, cholesteryl ester | Generator | Palmitate cholesteryl ester | Generator | Cholesterol ester(16:0) | HMDB | 1-Palmitoyl-cholesterol | HMDB | Cholesteryl 1-hexadecanoic acid | HMDB | Cholesterol ester(16:0/0:0) | HMDB | Cholesterol 1-hexadecanoate | HMDB | CE(16:0/0:0) | HMDB | Cholesterol 1-hexadecanoic acid | HMDB | Cholesterol 1-palmitoic acid | HMDB | Cholesterol 1-palmitoate | HMDB | Cholesteryl 1-palmitoate | HMDB | Cholesteryl 1-hexadecanoate | HMDB | 1-Hexadecanoyl-cholesterol | HMDB | Cholesteryl 1-palmitoic acid | HMDB | Cholest-5-en-3-yl palmitate | HMDB | Cholest-5-ene-3-beta-yl palmitate | HMDB | Cholesteryl palmitate | HMDB | Cholesteryl palmitic acid | HMDB | Hexadecanoate | HMDB | Hexadecanoic acid | HMDB | Hexadecanoic acid cholesteryl ester | HMDB | 5-Cholesten-3beta-ol stearate | HMDB | 5-Cholesten-3β-ol stearate | HMDB | Cholest-5-en-3beta-ol stearate | HMDB | Cholest-5-en-3β-ol stearate | HMDB | Cholesterol hexadecanoate | HMDB | CE(16:0) | Lipid Annotator |
|
---|
Chemical Formula | C43H76O2 |
---|
Average Mass | 625.0623 Da |
---|
Monoisotopic Mass | 624.58453 Da |
---|
IUPAC Name | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl hexadecanoate |
---|
Traditional Name | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl hexadecanoate |
---|
CAS Registry Number | Not Available |
---|
SMILES | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCCCCCCCC)[C@H](C)CCCC(C)C |
---|
InChI Identifier | InChI=1S/C43H76O2/c1-7-8-9-10-11-12-13-14-15-16-17-18-19-23-41(44)45-36-28-30-42(5)35(32-36)24-25-37-39-27-26-38(34(4)22-20-21-33(2)3)43(39,6)31-29-40(37)42/h24,33-34,36-40H,7-23,25-32H2,1-6H3/t34-,36+,37+,38-,39+,40+,42+,43-/m1/s1 |
---|
InChI Key | BBJQPKLGPMQWBU-JADYGXMDSA-N |
---|
Experimental Spectra |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
HMBC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | HSQC NMR | [1H, 13C] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | COSY NMR | [1H, 1H] NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, CDCl3, experimental) | bgnzk@missouri.edu | MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum | 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 1H NMR Spectrum (1D, 600.133705802, CDCl3, simulated) | bgnzk@missouri.edu | Sumner Lab, MU Metabolomics Center, University of Missouri, Columbia. MO, USA | Dr. Bharat Goel | 2024-05-02 | View Spectrum |
| Species |
---|
Species of Origin | Not Available |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Steroid esters |
---|
Direct Parent | Cholesteryl esters |
---|
Alternative Parents | |
---|
Substituents | - Cholesteryl ester
- Cholesterol
- Cholestane-skeleton
- Delta-5-steroid
- Carboxylic acid ester
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - Ludmir J, Alvarez JG, Mennuti MT, Gabbe SG, Touchstone JC: Cholesteryl palmitate as a predictor of fetal lung maturity. Am J Obstet Gynecol. 1987 Jul;157(1):84-8. [PubMed:3605272 ]
- Mansour S, Tocheva AS, Cave-Ayland C, Machelett MM, Sander B, Lissin NM, Molloy PE, Baird MS, Stubs G, Schroder NW, Schumann RR, Rademann J, Postle AD, Jakobsen BK, Marshall BG, Gosain R, Elkington PT, Elliott T, Skylaris CK, Essex JW, Tews I, Gadola SD: Cholesteryl esters stabilize human CD1c conformations for recognition by self-reactive T cells. Proc Natl Acad Sci U S A. 2016 Mar 1;113(9):E1266-75. doi: 10.1073/pnas.1519246113. Epub 2016 Feb 16. [PubMed:26884207 ]
- Morton RE: Specificity of lipid transfer protein for molecular species of cholesteryl ester. J Lipid Res. 1986 May;27(5):523-9. [PubMed:3734635 ]
- Martin CM, Nicholas HJ: Metabolism of cholesteryl palmitate by rat brain in vitro; formation of cholesterol epoxides and cholestane-3beta,5alpha,6beta-triol. J Lipid Res. 1973 Nov;14(6):618-24. [PubMed:4147522 ]
- MacKay AL, Wassall SR, Valic MI, Gorrissen H, Cushley RJ: 2H- and 31P-NMR studies of cholesteryl palmitate in sphingomyelin dispersions. Biochim Biophys Acta. 1980 Sep 2;601(1):22-33. doi: 10.1016/0005-2736(80)90510-6. [PubMed:7190843 ]
|
---|